Star Equity Holdings Inc (STRR)
0.9151
0.00 (0.00%)
USD |
NASDAQ |
May 02, 16:00
0.8995
-0.02
(-1.70%)
Pre-Market: 20:00
Star Equity Holdings Enterprise Value: 12.35M for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 02, 2024 | 12.35M |
May 01, 2024 | 12.41M |
April 30, 2024 | 12.27M |
April 29, 2024 | 12.60M |
April 26, 2024 | 12.11M |
April 25, 2024 | 11.76M |
April 24, 2024 | 11.55M |
April 23, 2024 | 11.88M |
April 22, 2024 | 11.65M |
April 19, 2024 | 11.52M |
April 18, 2024 | 11.32M |
April 17, 2024 | 11.79M |
April 16, 2024 | 11.71M |
April 15, 2024 | 11.87M |
April 12, 2024 | 12.03M |
April 11, 2024 | 12.23M |
April 10, 2024 | 12.58M |
April 09, 2024 | 12.42M |
April 08, 2024 | 12.88M |
April 05, 2024 | 12.42M |
April 04, 2024 | 12.74M |
April 03, 2024 | 12.58M |
April 02, 2024 | 12.39M |
April 01, 2024 | 12.36M |
March 28, 2024 | 11.91M |
Date | Value |
---|---|
March 27, 2024 | 12.03M |
March 26, 2024 | 11.96M |
March 25, 2024 | 12.27M |
March 22, 2024 | 12.42M |
March 21, 2024 | 11.95M |
March 20, 2024 | 12.38M |
March 19, 2024 | 12.11M |
March 18, 2024 | 12.11M |
March 15, 2024 | 12.26M |
March 14, 2024 | 12.26M |
March 13, 2024 | 12.27M |
March 12, 2024 | 11.79M |
March 11, 2024 | 11.79M |
March 08, 2024 | 12.26M |
March 07, 2024 | 12.58M |
March 06, 2024 | 12.88M |
March 05, 2024 | 12.85M |
March 04, 2024 | 12.56M |
March 01, 2024 | 12.88M |
February 29, 2024 | 12.88M |
February 28, 2024 | 13.03M |
February 27, 2024 | 12.88M |
February 26, 2024 | 12.88M |
February 23, 2024 | 12.88M |
February 22, 2024 | 12.92M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.721M
Minimum
Aug 15 2023
64.74M
Maximum
Feb 18 2021
34.15M
Average
38.57M
Median
May 18 2021
Enterprise Value Benchmarks
Delcath Systems Inc | 116.09M |
Exact Sciences Corp | 12.58B |
Illumina Inc | 20.14B |
CytoSorbents Corp | 35.40M |
Progyny Inc | 2.724B |
Enterprise Value Related Metrics
Net Income (Quarterly) | 1.728M |
Revenue (Quarterly) | 14.11M |
Total Expenses (Quarterly) | 14.91M |
EPS Diluted (Quarterly) | -0.02 |
Gross Profit Margin (Quarterly) | 20.23% |
Profit Margin (Quarterly) | 12.25% |
Earnings Yield | 152.7% |
Normalized Earnings Yield | -16.58 |